1. Ultrasound-guided percutaneous microwave ablation assisted by athree-dimensional visualization treatment platform combined with transcatheter arterial chemoembolization for a single large hepatocellular carcinoma 5 cm or larger: a preliminary clinical application
   He Ren et al, 2019, International Journal of Hyperthermia CrossRef
2. Combination therapy by transarterial injection of miriplatin-iodized oil suspension with radiofrequency ablation (RFA) versus microwave ablation (MWA) for small hepatocellular carcinoma: a comparison of therapeutic efficacy
   Noriyuki Miyamoto et al, 2021, Japanese Journal of Radiology CrossRef
3. Current status of the combination therapy of transarterial chemoembolization and local ablation for hepatocellular carcinoma
   Wei Li et al, 2019, Abdominal Radiology CrossRef
4. Impact of local tumor lesion treatments and preoperative indicators on the survival of patients with small hepatocellular carcinomas
   Yanyan Wei et al, 2018, Oncology Letters CrossRef
5. Percutaneous Radiofrequency Ablation with or without Chemolipiodolization for Hepatocellular Carcinoma: A Propensity-Score-Matched Analysis
   Kota Takaki et al, 2022, Journal of Clinical Medicine CrossRef
6. Radiofrequency ablation with four electrodes as a building block for matrix radiofrequency ablation: Ex vivo liver experiments and finite element method modelling. Influence of electric and activation mode on coagulation size and geometry
   Stefaan Mulier et al, 2020, Surgical Oncology CrossRef
7. Rethinking the Role of Radiation Therapy in the Treatment of Unresectable Hepatocellular Carcinoma: A Data Driven Treatment Algorithm for Optimizing Outcomes
   Mutlay Sayan et al, 2019, Frontiers in Oncology CrossRef
8. Ultra‐high‐performance liquid chromatography‐tandem mass spectrometry‐based metabolomics unveils the metabolic alterations in colon cancer mice during CT‐guided radiofrequency ablation
   Jin Cai et al, 2023, Biomedical Chromatography CrossRef
9. Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma
   Feng Duan et al, 2020, World Journal of Gastrointestinal Oncology CrossRef
10. Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progression
    Shoujin Cao et al, 2022, International Journal of Hyperthermia CrossRef
11. Improving Adjuvant Liver-Directed Treatment Recommendations for Unresectable Hepatocellular Carcinoma: An Artificial Intelligence–Based Decision-Making Tool
    Allen Mo et al, 2022, JCO Clinical Cancer Informatics CrossRef
12. Association of Addition of Ablative Therapy Following Transarterial Chemoembolization With Survival Rates in Patients With Hepatocellular Carcinoma
    Keara English et al, 2020, JAMA Network Open CrossRef
13. Unresectable hepatocellular carcinoma treatment with doxorubicin-eluting polyethylene glycol microspheres: a single-center experience
    Gerardo Tovar-Felice et al, 2021, Hepatic Oncology CrossRef
14. Combined Transarterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Infeasible for Ultrasound-Guided Percutaneous Radiofrequency Ablation: A Comparative Study with General Ultrasound-Guided Radiofrequency Ablation Outcomes
    Dong Ik Cha et al, 2023, Cancers CrossRef